Protective antigens from erythrocytic stages: recent progress and perspectives for the development of a vaccine
Luc Perrin1
Alan Shaw2
Geneva University Hospital, Department of Medicine, Geneva Blood Center, Geneva, Switzerland
Biogen SA, Carouge, Switzerland
Key words:
Full text available only in PDF format.
Texto completo disponível apenas em PDF.
Publication Dates
-
Publication in this collection
26 June 2009 -
Date of issue
1986